The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

3 Feb 2015 07:00

RNS Number : 8398D
Immunodiagnostic Systems Hldgs PLC
03 February 2015
 



 

 

RNS Announcement

3 February 2015

 

Immunodiagnostic Systems Holdings plc

Patricio Lacalle Appointed New Chief Executive Officer

Immunodiagnostic Systems Holdings plc ("IDS"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets quoted on AIM, today announces that Patricio Lacalle has been appointed Chief Executive Officer and will join IDS as a Director effective 1 April 2015.

Patricio is currently the CEO of Pulsion Medical Systems SE, a medical technology company with a leading market position in hemodynamic monitoring. In the four years which he has spent at Pulsion Patricio and his team were able to lead the company to international growth while significantly expanding the operating margin. Before Pulsion Patricio held a number of management positions at Forbo Adhesives and HB Fuller.

On 1 April 2015, Burkhard Wittek, Executive Chairman, will revert to being Non-Executive Chairman.

Dr Burkhard Wittek, Executive Chairman of Immunodiagnostic Systems, said "IDS is delighted to announce the appointment of Patricio as Chief Executive Officer. We have worked together at Pulsion and were able to build a company setting standards of business quality in its field. Patricio brings to IDS a strong business sense, a bias for action and great team building and leadership skills. Our leadership team at IDS is looking forward to working with Patricio and together achieving our ambitions for driving growth and profitability."

The following disclosures are made in accordance with AIM rule 17 and Schedule 2 paragraph (g) of the AIM Rules:

Carlos Patricio Lacalle Zando, aged 49 is currently a director of Pulsion Medical Systems SE, Germany, Pulsion Medical UK Ltd., Pulsion France S.A.R.L., Pulsion Austria GmbH, Pulsion Medical Inc., USA, Pulsion Benelux N.V., Belgium, Pulsion Pacific PTY., Australia, Pulsion Switzerland GmbH, Pulsion Poland Sp.z.o.o., Pulsion Iberica S.L, Spain, Pulsion Medical Systems S. de RL de CV, Mexico, Pulsion Medical Systems Medikal Ürünler Ticaret Limited Sirketi, Turkey and in the previous five years he has also been a director of Forbo Adhesives Deutschland GmbH and Forbo Adhesives Schweiz AG.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUQAPUPAPUP
Date   Source Headline
6th Dec 20182:59 pmRNSDirector/PDMR Shareholding
23rd Nov 20185:04 pmRNSHalf-year Report
19th Oct 20185:18 pmRNSH1 Trading Update
4th Sep 20188:00 amRNSCompletion of Share Buyback
30th Aug 20187:00 amRNSProposed Share Buyback
7th Aug 20185:48 pmRNSTransaction in Own Shares
7th Aug 20187:00 amRNSTransaction in Own Shares
1st Aug 20186:06 pmRNSTransaction in Own Shares
31st Jul 20186:02 pmRNSTransaction in Own Shares
26th Jul 20185:59 pmRNSResult of AGM
26th Jul 20187:00 amRNSAGM Statement
11th Jul 20185:33 pmRNSTransaction in Own Shares
20th Jun 20187:05 amRNSPublication of Annual Report and Accounts
20th Jun 20187:00 amRNSFinal Results
13th Jun 20185:07 pmRNSTransaction in Own Shares
6th Jun 20188:04 amRNSTransaction in Own Shares
20th Apr 20184:35 pmRNSTrading Statement
12th Apr 20185:21 pmRNSTransaction in Own Shares
6th Apr 20185:47 pmRNSTransaction in Own Shares
5th Apr 20182:16 pmRNSTransaction in Own Shares
29th Mar 20186:25 pmRNSDirector/PDMR Shareholding
29th Mar 20186:21 pmRNSDirector/PDMR Shareholding
29th Mar 20181:32 pmRNSLaunch of two new automated assays
29th Mar 20187:00 amRNSTransaction in Own Shares
26th Mar 20185:08 pmRNSTransaction in Own Shares
23rd Mar 20183:59 pmRNSTransaction in Own Shares
21st Mar 20185:50 pmRNSDirectorate Change
21st Mar 20181:08 pmRNSDirector/PDMR Shareholding
1st Mar 20184:50 pmRNSTransaction in Own Shares
22nd Feb 20185:02 pmRNSTransaction in Own Shares
21st Feb 20185:30 pmRNSTransaction in Own Shares
15th Feb 20185:20 pmRNSTransaction in Own Shares
13th Feb 201812:13 pmRNSTransaction in Own Shares
12th Feb 20181:22 pmRNSTransaction in Own Shares
6th Feb 20184:49 pmRNSTransaction in Own Shares
5th Feb 20183:19 pmRNSTransaction in Own Shares
2nd Feb 20182:47 pmRNSTransaction in Own Shares
24th Jan 20181:21 pmRNSTransaction in Own Shares
16th Jan 20187:00 amRNSPartnership Agreement with Technogenetics
15th Jan 20184:45 pmRNSTransaction in Own Shares
27th Dec 20175:16 pmRNSTransaction in Own Shares
24th Nov 20174:30 pmRNSHalf-year Report
23rd Nov 20175:15 pmRNSTransaction in Own Shares
14th Nov 201712:06 pmRNSTransaction in Own Shares
13th Nov 20175:37 pmRNSTransaction in Own Shares
2nd Nov 20176:05 pmRNSTransaction in Own Shares
1st Nov 20174:29 pmRNSAdditional Listing
1st Nov 20174:05 pmRNSTransaction in Own Shares
31st Oct 20176:22 pmRNSDirectorate Change
31st Oct 20176:03 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.